FDA OKs Subcutaneous Pembrolizumab for Solid Tumors – Medscape

1. FDA OKs Subcutaneous Pembrolizumab for Solid Tumors  Medscape
2. A New Shot for Cancer Is Convenient, but Poised to Keep Prices High  The New York Times
3. Merck scores FDA approval for subcutaneous Keytruda, securing potential blockbuster protection  

Continue Reading